Abstract Objectives: This study aimed to evaluate the cost-effectiveness of upadacitinib in patients with moderately to severely active ulcerative colitis (UC), who have had an inadequate response, lost response, or were intolerant to either conventional therapy...
Abstract: Background Patient reported-outcomes [PROs] are a major therapeutic goal in inflammatory bowel disease [IBD]. The study objective was to investigate the burden of IBD and unmet medical need in patients who receive biologic therapy in Greece. Methods Between...
Abstract:Background: While the clinical application of SII-ONCO-Bacillus Calmette–Guerin (BCG) for non-muscle-invasive bladder cancer (NMIBC) is well established in Greece, there is a lack of real-world data on its effectiveness and safety. This retrospective,...
Authors: OBJECTIVES: The objective of current study was to capture patients’ disease burden, satisfaction, and use of technology in adult patients with rheumatoid arthritis (RA) in Greece. METHODS: A cross-sectional survey was conducted in August –September of 2023....
Authors:OBJECTIVES: Ulcerative colitis (UC) requires life-long disease management. The study objective was to investigate the burden of UC and unmet medical need in patients who receive advanced (biologic or JAK inhibitor) therapy in Greece. METHODS: Between October...